Ritsuzo Kozuka, Masaru Enomoto, Yoshimi Yukawa-Muto, Naoshi Odagiri, Kohei Kotani, Hiroyuki Motoyama, Etsushi Kawamura, Atsushi Hagihara, Hideki Fujii, Sawako Uchida-Kobayashi, et al. Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy. Hepatology research : the official journal of the Japan Society of Hepatology. 2024. 54. 7. 615-626
Kohei Kotani, Norifumi Kawada. Recent Advances in the Pathogenesis and Clinical Evaluation of Portal Hypertension in Chronic Liver Disease. Gut and liver. 2024. 18. 1. 27-39
Naoshi Odagiri, Akihiro Tamori, Kohei Kotani, Hiroyuki Motoyama, Etsushi Kawamura, Atsushi Hagihara, Hideki Fujii, Sawako Uchida-Kobayashi, Masaru Enomoto, Norifumi Kawada. A case of hepatocellular carcinoma with "pseudoprogression" followed by complete response to atezolizumab plus bevacizumab. Clinical journal of gastroenterology. 2023. 16. 3. 392-396
Ritsuzo Kozuka, Akihiro Tamori, Masaru Enomoto, Yoshimi Muto-Yukawa, Naoshi Odagiri, Kohei Kotani, Hiroyuki Motoyama, Etsushi Kawamura, Atsushi Hagihara, Hideki Fujii, et al. Risk factors for liver-related and non-liver-related mortality following a sustained virological response after direct-acting antiviral treatment for hepatitis C virus infection in a real-world cohort. Journal of viral hepatitis. 2023. 30. 5. 374-385
Kohei Kotani, Masaru Enomoto, Sawako Uchida-Kobayashi, Akihiro Tamori, Yoshimi Yukawa-Muto, Naoshi Odagiri, Hiroyuki Motoyama, Ritsuzo Kozuka, Etsushi Kawamura, Atsushi Hagihara, et al. Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis. Journal of gastroenterology. 2023. 58. 4. 394-404
